Compare KEYS & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KEYS | BDX |
|---|---|---|
| Founded | 1939 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.9B | 54.6B |
| IPO Year | 2014 | 1998 |
| Metric | KEYS | BDX |
|---|---|---|
| Price | $307.26 | $197.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 16 |
| Target Price | ★ $418.00 | $195.57 |
| AVG Volume (30 Days) | 962.3K | ★ 1.4M |
| Earning Date | 11-19-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 2.12% |
| EPS Growth | ★ 39.89 | N/A |
| EPS | ★ 5.93 | 1.59 |
| Revenue | $5,375,000,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $32.38 | N/A |
| Revenue Next Year | $15.39 | $2.27 |
| P/E Ratio | ★ $55.67 | $124.49 |
| Revenue Growth | 7.95 | ★ 8.24 |
| 52 Week Low | $167.23 | $140.11 |
| 52 Week High | $389.93 | $213.08 |
| Indicator | KEYS | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 33.81 | 62.99 |
| Support Level | $270.75 | $195.63 |
| Resistance Level | $309.50 | $200.47 |
| Average True Range (ATR) | 12.32 | 3.73 |
| MACD | -4.29 | 0.38 |
| Stochastic Oscillator | 3.96 | 79.54 |
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.